Stock Analiz

Pacific Biosciences OF California, Inc. (PACB) stock forecast and price target

Price $1.96 · data as of November 13, 2026

12-month price target

Average target$2.74
Upside / downside+39.9%
Analysts7
ConsensusBuy
Low $2.00Average $2.74High $3.00

Gold marker: average target · white marker: today’s price ($1.96)

Analyst ratings

Strong buy 0Buy 4Hold 3Sell 0Strong sell 1

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.49+7.7%$157M
Next fiscal year
ends December 31, 2027
$-0.40+18.0%$178M
Next quarter
ends December 31, 2026
$-0.12−2.1%$41M
Quarter after
ends March 31, 2027
$-0.10+14.7%$41M

Consensus of the analysts covering Pacific Biosciences OF California, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the Pacific Biosciences OF California stock price target?

The average 12-month target from 7 analysts is $2.74, 39.9% above the current price of $1.96 Targets range from $2.00 to $3.00.

Is Pacific Biosciences OF California a buy according to analysts?

The consensus rating is “Buy” (4 buy, 3 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Pacific Biosciences OF California expected to earn?

Analysts expect EPS of $-0.49 for the fiscal year ending December 31, 2026 and $-0.40 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.